Krystal Biotech Inc reports results for the quarter ended in January 1 - Earnings Summary

Krystal Biotech

04/11/2024 15:19

* Krystal Biotech Inc  KRYS.OQ  reported quarterly adjusted
earnings of 91 cents​​ per share for the quarter ended January
1, higher than the same quarter last year, when the company
reported EPS of -69 cents.  The mean expectation of
nine analysts for the quarter was for earnings of 90 cents per
share. Wall Street expected results to range from 63 cents
to $1.16 per share.
    * Revenue rose 879.9% to $83.84 million from a year ago;
analysts
expected $82.95 million. 
    * Krystal Biotech Inc's reported EPS for the quarter was 91
cents​.
    * The company reported quarterly net income of $27.18
million.
    * Krystal Biotech Inc shares had fallen by 3.1% this
quarter and
gained 42.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1% in
the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Krystal Biotech
Inc is 206.00 
This summary was machine generated from LSEG data November 4 at
03:19 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.90           0.91           Beat
 Jun. 30 2024      0.58           0.53           Missed
 Mar. 31 2024      0.15           0.03           Missed
 Dec. 31 2023      -0.42          0.30           Beat